scholarly article | Q13442814 |
P356 | DOI | 10.1002/CBIC.201300335 |
P698 | PubMed publication ID | 24115455 |
P50 | author | Frans A.A. Mulder | Q58870548 |
P2093 | author name string | Jakob T Nielsen | |
Jan K Jensen | |||
Knud J Jensen | |||
Mingdong Huang | |||
Peter A Andreasen | |||
Longguang Jiang | |||
Niels Chr Nielsen | |||
Anni Christensen | |||
Berit Paaske | |||
Renée Roodbeen | |||
P2860 | cites work | TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts | Q24651272 |
Processing of X-ray diffraction data collected in oscillation mode | Q26778468 | ||
Structural basis of specificity of a peptidyl urokinase inhibitor, upain-1 | Q27647131 | ||
The binding mechanism of a peptidic cyclic serine protease inhibitor | Q27671270 | ||
Bicyclic peptide inhibitor reveals large contact interface with a protease target | Q27677040 | ||
Bicyclic peptide ligands pulled out of cysteine-rich peptide libraries | Q27684366 | ||
Coot: model-building tools for molecular graphics | Q27860505 | ||
The CCPN data model for NMR spectroscopy: development of a software pipeline | Q27860601 | ||
Thrombin and vascular inflammation | Q28246124 | ||
Random coil chemical shifts in acidic 8 M urea: implementation of random coil shift data in NMRView | Q30619296 | ||
Selection of a cyclic nonapeptide inhibitor to alpha-chymotrypsin using a phage display peptide library | Q32049631 | ||
A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibition | Q33222784 | ||
Novel peptide inhibitors of human kallikrein 2. | Q33235991 | ||
Phage-encoded combinatorial chemical libraries based on bicyclic peptides | Q33456683 | ||
Elucidation of the contribution of active site and exosite interactions to affinity and specificity of peptidylic serine protease inhibitors using non-natural arginine analogs | Q33947706 | ||
The plasminogen activation system in tumor growth, invasion, and metastasis | Q34008816 | ||
Strategies for the inhibition of serine proteases | Q34256075 | ||
A simple method to predict protein flexibility using secondary chemical shifts | Q34462699 | ||
Inhibitors of the protease domain of urokinase-type plasminogen activator | Q34947102 | ||
uPA and uPAR in fibrinolysis, immunity and pathology | Q35846404 | ||
Identification of novel peptide inhibitors for human trypsins. | Q43175517 | ||
A software tool for the prediction of Xaa-Pro peptide bond conformations in proteins based on 13C chemical shift statistics | Q44258185 | ||
Bicyclic peptides with optimized ring size inhibit human plasma kallikrein and its orthologues while sparing paralogous proteases | Q47316404 | ||
The CCPN project: an interim report on a data model for the NMR community | Q47616220 | ||
Random coil chemical shift for intrinsically disordered proteins: effects of temperature and pH. | Q53079294 | ||
P433 | issue | 16 | |
P304 | page(s) | 2179-2188 | |
P577 | publication date | 2013-10-02 | |
P1433 | published in | ChemBioChem | Q634395 |
P1476 | title | Bicyclic peptide inhibitor of urokinase-type plasminogen activator: mode of action | |
P478 | volume | 14 |
Q34784373 | A cyclic peptidic serine protease inhibitor: increasing affinity by increasing peptide flexibility |
Q36394825 | Bicyclic Peptides as Next-Generation Therapeutics. |
Q30367509 | Constraining cyclic peptides to mimic protein structure motifs. |
Q35231270 | Repositioning the substrate activity screening (SAS) approach as a fragment-based method for identification of weak binders |
Q47098588 | Structural Principles in the Development of Cyclic Peptidic Enzyme Inhibitors |
Search more.